Pancreatic Cancer Research

ResearcherKumamoto UniversityNo recent work listed

Kensuke Yamamura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0506-6394; OpenAlex author ID A5068838933. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 4 papers · 2019: 1 paper · 2020: 4 papers · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 13

  1. Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-022-02057-1↗
  2. A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33284↗
  3. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejca.2020.12.031↗
  4. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases. Co-author DOI 10.1053/j.gastro.2020.04.057↗
  5. Successful Treatment for the Recurrent Liver Metastases of the Pancreatic Cancer by Multimodality Therapy. Co-author DOI 10.1097/mpa.0000000000001622↗
  6. A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-4044↗
  7. Efficacy of Staging Laparoscopy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.14037↗
  8. Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07266-2↗
  9. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2017.08.016↗
  10. Multiple Primary Cancers in Patients with Pancreatic Cancer. Co-author DOI 10.1177/000313481808401205↗
  11. Thoracic wall muscle metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-017-0393-0↗
  12. Cystic gastric metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-018-0443-2↗
  13. The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases. Co-author DOI 10.1007/s10147-016-0975-z↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajay Goel · 5 shared papers, 2020–2023 · strength 0.68
  2. Satoshi Nishiwada · 4 shared papers, 2020–2023 · strength 0.55
  3. Masayuki Sho · 4 shared papers, 2020–2023 · strength 0.55
  4. Daisuke Hashimoto · 6 shared papers, 2016–2020 · strength 0.45
  5. Takanobu Yamao · 5 shared papers, 2018–2020 · strength 0.44
  6. Kota Nakamura · 3 shared papers, 2020–2023 · strength 0.40
  7. Shigeki Nakagawa · 5 shared papers, 2018–2019 · strength 0.39
  8. Katsunori Imai · 5 shared papers, 2016–2020 · strength 0.38
  9. Hirohisa Okabe · 5 shared papers, 2016–2020 · strength 0.38
  10. Kota Arima · 5 shared papers, 2016–2020 · strength 0.36
  11. Yuki Kitano · 5 shared papers, 2016–2020 · strength 0.36
  12. Hideo Baba · 4 shared papers, 2016–2020 · strength 0.35
  13. Akira Chikamoto · 5 shared papers, 2016–2018 · strength 0.34
  14. Tatsunori Miyata · 4 shared papers, 2018–2020 · strength 0.31
  15. Kenji Nakagawa · 2 shared papers, 2021–2023 · strength 0.28
  16. Minako Nagai · 2 shared papers, 2021–2023 · strength 0.28
  17. Hideo Baba · 2 shared papers, 2020–2021 · strength 0.25
  18. Takahiro Akahori · 2 shared papers, 2020–2021 · strength 0.24
  19. Masayo Tsukamoto · 3 shared papers, 2018–2019 · strength 0.23
  20. Naoki Umezaki · 3 shared papers, 2018 · strength 0.23
  21. Hiromitsu Hayashi · 2 shared papers, 2019–2020 · strength 0.20
  22. Hideo Baba · 2 shared papers, 2018–2020 · strength 0.17
  23. Suguru Yamada · 1 shared paper, 2023 · strength 0.17
  24. Taichi Terai · 1 shared paper, 2023 · strength 0.17
  25. Yasuhiro Kodera · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.